Dr. Mark Epstein, a plastic surgeon in New York, shared the most common procedures his male clients get, from filler to ...

When I say I’ve been getting Botox my entire adult life, I’m not exaggerating one bit—I started at the ripe, young age of 19 to help prevent wrinkles from forming, and I’ve honestly never ...

A gender gap is widening in the 2025 federal election, with more men relating to the Conservative leader than women You can save this article by registering for free here. Or sign-in if you have ...

He described the scene in one word: “Hell.” Three men died in the fire, which started just after 1:30 a.m. on Chevy Chase Street in the Jamaica Estates neighborhood, a three-minute drive from ...

When I say I’ve been getting Botox my entire adult life, I’m not exaggerating one bit—I started at the ripe, young age of 19 to help prevent wrinkles from forming, and I’ve honestly never ...

Diana Lehaf says the Botox injections she received at the Austin location last December left her badly disfigured. "I wasn't able to look at myself in the mirror. I really looked like a monster ...

John Korir won the men's race in the 2025 Boston Marathon on Monday, while Sharon Lokedi held off 2024 winner Hellen Obiri to win the women's race. Korir became the second member of his family to ...

But when White Lotus actress Aimee Lou Wood, 31, recently described herself as "very anti-Botox,", I couldn't help but relate. Not because I'm on a soapbox about what anyone should or shouldn't ...

The 2025 DIII men's volleyball championship is here. All matches will be streamed live on NCAA.com with action running through Sunday, April 27, at the Cregger Center in Salem, Virginia.

Dominating its economy, on the other hand, are the not-so-pretty windowless grey factory units that manufacture the world’s entire supply of Botox for a US company. And Donald Trump wants pharma ...

About TAR-210 TAR-210 is an investigational intravesical erdafitinib releasing system. The safety and efficacy of TAR-210 is being evaluated in a Phase 1 study (NCT05316155) in patients with ...

1 Nadofaragene firadenovec is the first and only intravesical non-replicating gene therapy approved by the U.S. Food and Drug Administration (FDA) in this patient population. 2 The product is ...